Five RCTs recently published in mainstream scientific journals that confirm major, statistically significant benefits of ivermectin against COVID-19 as reported in several prior RCTs

Five RCTs recently published in mainstream scientific journals that confirm major, statistically significant benefits of ivermectin against COVID-19 as reported in several prior RCTs

Note that views expressed in this opinion article are the writer’s personal views and not necessarily those of TrialSite.

Abstract

Major benefits of ivermectin (IVM) treatment for COVID-19 have been known since the results of 20  such randomized controlled trials (RCTs) were reported, as compiled in January 2021. Of the eight of these RCTs that tracked mortality or morbidity in patients with serious cases, seven showed statistically significant clinical improvements. The pooled mortality reduction in these eight RCTs was 78% in the treatment vs. controls groups, and the RCT that used the highest dose of IVM reported a 92% reduction in mortality (p < 0.001). Three RCTs for IVM prevention of COVID-19 and two animal studies of IVM at low human-equivalent doses likewise reported pronounced efficacy. Here we note the recent publication of RCTs for IVM treatment or prevention of COVID-19 in mainstream scientific journals that confirm these previously reported findings.

Background

The consistently observed, major benefits of ivermectin (IVM) for COVID-19 treatment have been known since a January 2021 meta-study compiled results of 20 such randomized clinical trials (R...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee